Autoimmune disease caused by spike protein and potential management approaches

Autoimmune disease caused by spike protein and potential management approaches

There is growing evidence that spike protein could result in anti-ACE2 antibodies. This in most cases is a normal (homeostatic) mechanism. However, in some individuals it can last longer and become problematic. Let's review the possible therapies in light of the pathogenesis. Educational material only. Not a medical advice. Please discuss these therapies with your doctor and follow his advice.

Buy me a coffee :-)
Become my patron:
Looking to support my educational work? Donate here:

Reference URL list from Tuesday, Dec. 28 2021

DrBeen: Continuing Medical Education Online | USMLE Prep | CME and CE marketplace | Nurse Practitioner and Physician Assistant Training Programs | Medical Student Training

ACE2-targeting monoclonal antibody as potent and broad-spectrum coronavirus blocker | Signal Transduction and Targeted Therapy

Development of ACE2 autoantibodies after SARS-CoV-2 infection - PMC

I-RECOVER Protocol - FLCCC | Front Line COVID-19 Critical Care Alliance

#drbeen #koolbeens #COVID

This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only.
Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional.
Be the first to comment